Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy

Cuylan, Zeliha; Meydanli, Mehmet; Sari, Mustafa; Akbayir, Ozgur; Celik, Husnu; Dede, Murat; Sahin, Hanifi; Gungorduk, Kemal; Kuscu, Esra; ÖZGÜL, NEJAT; Gungor, Tayfun; AYHAN, ALİ

doi:10.1111/jog.13663

Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy

Atıf İçin Kopyala

Cuylan Z. F., Meydanli M. M., Sari M. E., Akbayir O., Celik H., Dede M., ...Daha Fazla

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, cilt.44, sa.7, ss.1284-1293, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 7
Basım Tarihi: 2018
Doi Numarası: 10.1111/jog.13663
Dergi Adı: JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1284-1293
Hacettepe Üniversitesi Adresli: Evet

Özet

ObjectiveTo identify factors predictive of poor prognosis in women with stage III nonserous epithelial ovarian cancer (EOC) who had undergone maximal or optimal primary cytoreductive surgery (CRS) followed by six cycles of intravenous carboplatin/paclitaxel chemotherapy.